Suppr超能文献

该国作为欧盟(EU)耐药结核病(DR-TB)高负担国家之一,其抗击结核病的历史经验与实践。

The historical experience and practice of fight against tuberculosis in country which is one of the high drug resistant-tuberculosis (DR-TB) burden countries in European Union (EU).

作者信息

Korablioviene J, Mauricas M, Caplinskas S, Zagrebneviene G, Korabliov P

机构信息

State Research Institute Centre for Innovative Medicine, Vilnius, Lithuania.

Centre for Communicable Diseases and AIDS, Vilnius, Lithuania.

出版信息

J Prev Med Hyg. 2018 Dec 15;59(4):E328-E335. doi: 10.15167/2421-4248/jpmh2018.59.4.926. eCollection 2018 Dec.

Abstract

Despite considerable efforts and quite early initiated anti-tuberculosis (TB) actions, Lithuania still remains one of the European Union (EU) countries with the highest tuberculosis rates, especially multidrug-resistant (MDR) TB. According to the European Centre for Disease Prevention and Control, in 2016, 58 994 cases of TB were reported in 30 EU/European Economic Area (EEA) countries. MDR TB was reported for 3.7% of 36 071 cases with drug susceptibility testing results and continues to be highest in the three Baltic countries - Estonia, Latvia and Lithuania. In this article we present the Lithuanian anti-TB action history review and comparison with other countries in this area of action. Literature review was performed by using documents available in the Martynas Mazvydas Library's resource, articles of foreign authors and archival materials. According to archaeological studies, tuberculosis was common in Europe including Lithuania in the Middle Ages. Tuberculosis reporting started in Lithuania in 1926. The first tuberculosis sanatorium in Lithuania was opened in 1891. Patients were treated with sun bathing procedures, fresh air and sunlight. Later the treatment included pneumothorax, toracocaustic, toracoplastic, treatment with gold products and other procedures. Lithuania introduced directly observed treatment, short course therapy (DOTS) in 1999, and since 2007 it has been working in accordance with the requirements of this strategy.

摘要

尽管付出了巨大努力且很早就启动了抗结核行动,但立陶宛仍是欧盟国家中结核病发病率最高的国家之一,尤其是耐多药结核病。根据欧洲疾病预防控制中心的数据,2016年,30个欧盟/欧洲经济区国家报告了58994例结核病病例。在36071例有药敏试验结果的病例中,耐多药结核病报告率为3.7%,在波罗的海三国——爱沙尼亚、拉脱维亚和立陶宛中仍然最高。在本文中,我们介绍立陶宛抗结核行动的历史回顾,并与该行动领域的其他国家进行比较。通过使用马尔蒂纳斯·马兹维达斯图书馆资源中的文件、外国作者的文章和档案材料进行文献综述。根据考古研究,结核病在中世纪的欧洲包括立陶宛都很常见。立陶宛于1926年开始报告结核病。立陶宛的第一家结核病疗养院于1891年开业。患者接受日光浴治疗、呼吸新鲜空气和晒太阳。后来的治疗方法包括气胸、烧灼胸廓、胸廓成形术、用金制品治疗等。立陶宛于1999年引入直接观察治疗短程疗法(DOTS),自2007年以来一直按照该战略的要求开展工作。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验